Group 1 - The core point of the article is that Eucan Vision Bio-B (01477) has seen a significant drop in its stock price, falling over 13% following its removal from the Hang Seng Composite Index [1] - As of the report, the stock price is at 9.84 HKD with a trading volume of 224 million HKD [1] - The Hang Seng Index Company announced its semi-annual index adjustment results on August 22, with changes effective after market close on September 5 and starting September 8 [1] Group 2 - Eucan Vision Bio-B reported a revenue of 294 million RMB for the mid-term of 2025, representing a year-on-year growth of 75.4% [1] - The company recorded a net loss of 132 million RMB, which is a 12.6% reduction compared to the previous year [1] - The basic loss per share is reported at 0.17 RMB [1]
港股异动 欧康维视生物-B(01477)跌超13% 遭剔除恒生综合指数 上半年净亏损1.32亿元